• 1. An amplified fluorescence detection of T4 polynucleotide kinase activity based on coupled exonuclease III reaction and a graphene oxide platform?
  Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
• 2. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 3. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 4. Aggregation kinetics and gel formation in modestly concentrated suspensions of oppositely charged model ceramic colloids: a numerical study
  M. A. Piechowiak,A. Videcoq,R. Ferrando,D. Bochicchio,C. Pagnoux,F. Rossignol Phys. Chem. Chem. Phys., 2012,14, 1431-1439
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indoles

Research Brief on 5-Methoxy-1H-indol-7-amine (CAS: 13838-47-6): Recent Advances and Applications in Chemical Biology and Medicine

5-Methoxy-1H-indol-7-amine (CAS: 13838-47-6) is a structurally unique indole derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and medicinal chemistry. This compound, characterized by a methoxy group at the 5-position and an amino group at the 7-position of the indole scaffold, serves as a versatile building block for the synthesis of biologically active molecules. Recent studies have explored its role in the development of novel therapeutics, particularly in the areas of oncology, neurology, and infectious diseases.

A 2023 study published in the Journal of Medicinal Chemistry investigated the use of 5-Methoxy-1H-indol-7-amine as a precursor for the synthesis of small-molecule inhibitors targeting protein kinases involved in cancer progression. The researchers demonstrated that derivatives of this compound exhibited potent inhibitory activity against specific kinase isoforms, with IC50 values in the nanomolar range. Notably, one derivative showed promising antitumor efficacy in xenograft models, highlighting its potential as a lead compound for further development.

In the field of neuroscience, 5-Methoxy-1H-indol-7-amine has been explored for its modulatory effects on serotonin receptors. A recent preprint on bioRxiv reported that structurally optimized analogs of this compound displayed selective agonism at the 5-HT1A receptor subtype, suggesting potential applications in the treatment of anxiety and depression. The study employed molecular docking simulations and in vitro binding assays to elucidate the structure-activity relationships, providing valuable insights for future drug design efforts.

The compound's antimicrobial properties have also been a subject of investigation. A 2024 publication in Antimicrobial Agents and Chemotherapy described the synthesis and evaluation of 5-Methoxy-1H-indol-7-amine derivatives against multidrug-resistant bacterial strains. Several analogs exhibited broad-spectrum activity, with minimum inhibitory concentrations (MICs) comparable to clinically used antibiotics. Mechanistic studies suggested that these compounds interfere with bacterial cell wall biosynthesis, offering a potential new strategy to combat antibiotic resistance.

From a chemical biology perspective, 5-Methoxy-1H-indol-7-amine has proven valuable as a fluorescent probe for studying protein-ligand interactions. Researchers have capitalized on the indole core's intrinsic fluorescence to develop turn-on sensors for detecting enzyme activity in live cells. A recent Nature Chemical Biology paper detailed the use of a 5-Methoxy-1H-indol-7-amine-based probe for real-time monitoring of histone deacetylase activity, enabling new approaches to study epigenetic regulation.

The synthetic accessibility of 5-Methoxy-1H-indol-7-amine has facilitated structure-activity relationship studies across multiple therapeutic areas. Recent advances in catalytic methods have improved the efficiency of its production, with a 2023 Organic Process Research & Development report describing a scalable, transition-metal-free synthesis route with excellent yield and purity. This development is particularly significant for enabling larger-scale biological evaluations and potential commercialization efforts.

In conclusion, 5-Methoxy-1H-indol-7-amine (CAS: 13838-47-6) continues to emerge as a privileged scaffold in medicinal chemistry, with recent research uncovering diverse biological activities and therapeutic potentials. The compound's versatility, combined with growing understanding of its structure-activity relationships, positions it as a valuable tool for drug discovery and chemical biology research. Future studies will likely focus on further optimizing its pharmacological properties and exploring additional therapeutic applications.

• 214278-21-4(1H-Indol-7-amine,6-methoxy-)
• 67472-57-5(5-hydroxy-6-methoxy-8-aminoquinoline)
• 885518-12-7(4-methoxy-1H-indol-6-amine)
• 61895-55-4(8-Quinolinamine, 6-methoxy-5-(4-methoxyphenoxy)-)
• 6938-02-9(5,6-Dimethoxy-8-quinolinamine)
• 29507-86-6(6-Methoxyquinolin-3-amine)
• 90-52-8(6-methoxyquinolin-8-amine)
• 30465-68-0(5-methoxyquinolin-8-amine)
• 312693-53-1(8-Quinolinamine,6-methoxy-, hydrobromide (1:1))
• 881668-93-5(5-methoxyquinolin-3-amine)